Skip to content

A Study on the Mechanism by Which "Ovarian Regulation Acupuncture" Improves Ovarian Function in Patients with Post-Ovarian Insufficiency (POI) Through Regulation of Glu/GABA Levels, Using Magnetic Resonance Spectroscopy Imaging Combined with Metabolomics

A Study on the Mechanism by Which "Ovarian Regulation Acupuncture" Improves Ovarian Function in Patients with Post-Ovarian Insufficiency (POI) Through Regulation of Glu/GABA Levels, Using Magnetic Resonance Spectroscopy Imaging Combined with Metabolomics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001125
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ovarian insufficiency

Interventions

Acupuncture group:Acupuncture and Electroacupuncture
Sham acupuncture group:Sham acupuncture and sham electroacupuncture

Sponsors

The First Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for POI; be between 25 and 40 years of age and have regular menstrual cycles; have received no other treatment in the 2 months prior to enrollment; voluntarily agree to participate in this study and be able to actively cooperate with the study protocol; and sign an informed consent form. Participants who meet all five of the above criteria will be enrolled in the study.

Exclusion criteria

Exclusion criteria: Congenital abnormalities of the reproductive organs; patients with severe concomitant diseases of the cardiovascular, hepatic, renal, hematopoietic, or nervous and psychiatric systems, as well as conditions such as diabetes or hypertension; patients who have undergone unilateral or bilateral oophorectomy; patients who are unable to tolerate blood tests or ultrasound examinations during the study, or who are unable to complete acupuncture sessions or the full course of treatment; patients currently participating in other clinical trials; patients who refuse to sign the informed consent form. Any participant meeting any of the above criteria will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Follicle-stimulating hormone;estradiol;Luteinizing hormone;Anti-Müllerian hormone;

Secondary

MeasureTime frame
Number of follicles;Modified Kupperman Score;Quality of Life Score for Perimenopausal Women;Anxiety Self-Rating Scale Score;Serum glutamate;Serum gamma-aminobutyric acid;Serum serotonin;Glutamate in the hypothalamus and pituitary gland;Gamma-aminobutyric acid in the hypothalamus and pituitary gland;Serotonin in the hypothalamus and pituitary gland;

Countries

China

Contacts

Public ContactLiu Xiaojuan

The First Affiliated Hospital of Hunan University of Chinese Medicine

599132021@qq.com13607809509

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026